HVD(P)s? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-01-04 11:47 (1430 d 13:56 ago) – Posting: # 22167
Views: 2,533

Hi 0521,

❝ But can you first clarify the acronym for "GL"?

❝ Please try not to use any abbreviations, which makes it painful for non-native English speakers to understand.


Sorry. In the future & if in doubt see the [image] Abbreviations on top of the page.

❝ "Guidance for Industry"?

❝ "Guidelines"?


Any would do.

❝ If it is "Guidelines", what kind of "Guidelines" do you want to get?

❝ RSABE? ABE?


Abbreviations, right? :-D
I was interested in the former but the latter would be fine as well.

❝ Maybe what you want is this: …


Almost! Seemingly it is for reference-scaling of narrow therapeutic index drugs. I’m looking for reference-scaling of highly variable drugs / drug products HVD(P)s.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,332 posts in 4,899 threads, 1,660 registered users;
20 visitors (0 registered, 20 guests [including 7 identified bots]).
Forum time: 01:44 CET (Europe/Vienna)

I don’t write drafts.
I write from the beginning to the end,
and when it’s finished, it’s done.    Clifford Geertz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5